Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis

Inclusion Criteria: * more than 18 years old * patient with diagnosis of liver cirrhosis Child Pugh A-B * Patients without previous hepatocellular carcinoma in whom ultrasound detects a suspicious hepatic lesion; solitary solid and well-defined nodule between 10 and 20mm * patients in whom diagnosis of hepatocellular carcinoma is a clinical need prior to treatment indication * patient that agree to participate signing informed consent form Exclusion Criteria: * Patients with poor liver function who would have undergone transplantation even without hepatocellular carcinoma diagnosis (Child-Pugh C) * patients with previous diagnosis of hepatocellular carcinoma * patients with significant comorbidities that could prevent the optimum therapeutic decision in case of positive diagnosis of hepatocellular carcinoma * patients with severe clotting alterations that contraindicate the fine-needle biopsy -Patients with chronic kidney disease or glomerular filtration rate \< 30 ml/min * patients with contraindications to perform magnetic resonance imaging (pacemaker, claustrophobia...) * Known hypersensitivity to study drugs or excipients * pregnancy or breastfeeding